| Form type | Sec Links | Description | Filing date | Reporting date |
|---|---|---|---|---|
| SC 13G | Report | Jul 8, 2024 | ||
| SC 13G | Report | Feb 14, 2024 | ||
| SC 13G/A | Report | Feb 14, 2024 | ||
| SC 13G/A | Report | SC 13G/A | Feb 14, 2024 | |
| SC 13G | Report | SC 13G | Feb 14, 2024 | |
| SC 13G | Report | Feb 14, 2024 | ||
| SC 13G | Report | JHG PLC OWNS >5% | Feb 14, 2024 | |
| SC 13G/A | Report | NEUROGENE INC. | Feb 14, 2024 | |
| SC 13G | Report | Dec 27, 2023 | ||
| SC 13G/A | Report | SC 13G/A | Dec 22, 2023 | |
| SC 13G/A | Report | SC 13G/A | Feb 14, 2023 | |
| SC 13G | Report | SC 13G | Feb 3, 2023 | |
| SC 13G/A | Report | Jan 19, 2023 | ||
| SC 13G | Report | NEOLEUKIN THERAPEUTICS, INC. | Dec 30, 2022 | |
| SC 13G | Report | Jul 19, 2022 | ||
| SC 13G | Report | Jul 15, 2022 | ||
| SC 13G | Report | Jul 8, 2022 | ||
| SC 13G | Report | Jul 7, 2022 | ||
| SC 13G/A | Report | SC 13G/A | Feb 14, 2022 | |
| SC 13G/A | Report | Feb 14, 2022 | ||
| SC 13G/A | Report | SC 13G/A | Feb 11, 2022 | |
| SC 13G/A | Report | SC 13G/A | Feb 11, 2022 | |
| SC 13G | Report | SC 13G | Feb 10, 2022 | |
| SC 13G/A | Report | Feb 3, 2022 | ||
| SC 13G | Report | SC 13G | Feb 16, 2021 | |
| SC 13G/A | Report | Feb 16, 2021 | ||
| SC 13G | Report | SC 13G | Feb 12, 2021 | |
| SC 13G | Report | SC 13G | Feb 12, 2021 | |
| SC 13G | Report | Feb 2, 2021 | ||
| SC 13G/A | Report | SC 13G/A | Feb 14, 2020 | |
| SC 13G | Report | SC 13G | Feb 13, 2020 | |
| SC 13G | Report | SC 13G | Feb 13, 2020 | |
| SC 13G | Report | Dec 27, 2019 | ||
| SC 13G/A | Report | Feb 14, 2019 | ||
| SC 13G/A | Report | Feb 14, 2019 | ||
| SC 13G/A | Report | Jan 25, 2019 | ||
| SC 13G | Report | Jul 16, 2018 | ||
| SC 13G/A | Report | Jul 10, 2018 | ||
| SC 13G/A | Report | SCHEDULE 13G/A | Feb 14, 2018 | |
| SC 13G/A | Report | Feb 14, 2018 | ||
| SC 13G/A | Report | Feb 5, 2018 | ||
| SC 13G/A | Report | Jan 9, 2018 | ||
| SC 13G/A | Report | AMENDED SC 13G | Feb 14, 2017 | |
| SC 13G/A | Report | SC 13G/A | Feb 14, 2017 | |
| SC 13G/A | Report | SC 13G/A | Feb 14, 2017 | |
| SC 13G/A | Report | Feb 9, 2017 | ||
| SC 13G/A | Report | Feb 6, 2017 | ||
| SC 13G/A | Report | Jan 19, 2017 | ||
| SC 13G | Report | AQXP AS OF 09/30/2016 | Oct 11, 2016 | |
| SC 13G/A | Report | SC 13G/A | Feb 16, 2016 | |
| SC 13G | Report | VENTURES WEST 8 L.P. | Feb 16, 2016 | |
| SC 13G/A | Report | AMENDMENT NO. 1 TO SC 13G/A | Feb 12, 2016 | |
| SC 13G/A | Report | SCHEDULE 13G/A FOR AQUINOX PHARMACEUTICALS | Feb 12, 2016 | |
| SC 13G/A | Report | SC 13G/A | Feb 12, 2016 | |
| SC 13G/A | Report | Feb 3, 2016 | ||
| SC 13G | Report | Jan 28, 2016 | ||
| SC 13G | Report | SCHEDULE 13G | Sep 21, 2015 | |
| SC 13G | Report | SC 13G | Aug 24, 2015 | |
| SC 13G/A | Report | SCHEDULE 13G AMENDMENT 1 | Aug 18, 2015 | |
| SC 13G/A | Report | SC 13G/A | Feb 17, 2015 | |
| SC 13G | Report | SC 13G | Feb 12, 2015 | |
| SC 13G | Report | SC 13G | Feb 11, 2015 | |
| SC 13G | Report | Feb 9, 2015 | ||
| SC 13G | Report | SCHEDULE 13G FOR AQUINOX PHARMACEUTICALS FOR JOHNSON & JOHNSON | Feb 6, 2015 | |
| SC 13G | Report | SC 13G | Apr 10, 2014 | |
| SC 13G | Report | SCHEDULE 13G | Mar 21, 2014 |